NCI launches exceptional responders initiative: Researchers will attempt to identify why some patients respond to treatment so much better than others.Published in:2015By:Printz, CarriePublication type:Other
Cancer: Reshaping the cancer clinic.Published in:Nature, 2015, v. 527, n. s7576, p. S10, doi. 10.1038/527S10aBy:Schmidt, CharliePublication type:Article
Roche buys $1 billion majority stake in Foundation.Published in:Nature Reviews Drug Discovery, 2015, v. 14, n. 3, p. 155, doi. 10.1038/nrd4568By:Mullard, AsherPublication type:Article
Roche spends $1 billion on Foundation Medicine's tumor profiling.Published in:Nature Biotechnology, 2015, v. 33, n. 3, p. 215, doi. 10.1038/nbt0315-215By:Ratner, MarkPublication type:Article
Foundation Medicine.Published in:Nature Biotechnology, 2012, v. 30, n. 1, p. 14, doi. 10.1038/nbt0112-14By:Eisenstein, MichaelPublication type:Article